<unk>  is a hyperammonemia agent that is FDA approved for the treatment of acute hyperammonemia in patients with NAGS deficiency, maintenance therapy for chronic hyperammonemia in patients with NAGS deficiency.   Common adverse reactions include abdominal pain, diarrhea, vomiting, anemia,  infectious disease, headache,  infection of ear, nasopharyngitis, tonsillitis, fever.
Carglumic acid
Ioxaglic acid
Sucralfate
Hexetidine
Guanoclor
Rabeprazole
Lansoprazole
Thiocolchicoside